- You Might Fare Better If Your Doctor Is Female, Study Finds
- CDC Launches Online ‘Heat Forecaster’ Tool as Another Summer Looms
- Biden Administration Sets Nursing Home Staffing Minimums
- Neosporin Ointment in the Nose Might Be Potent Antibiotic
- Physical Ills Often Plague People With Schizophrenia, Bipolar
- Taking Psilocybin for Depression? Relationship With Therapist Is Key
- Stick to Heimlich Maneuver Not ‘Anti-Choking’ Devices, FDA Says
- Women in the Military at Risk for Low-Weight Babies
- Repeat Blasts Can Damage Soldiers’ Brains, Study Confirms
- Few Young Adults Could Administer Naloxone to Reverse Fentanyl Overdose
Animal Trials Show Promise for Treating Eye Cancer
New findings about the genetic roots of eye melanoma could lead to more effective treatments, scientists say. They also report an existing drug shows benefits as a treatment for eye tumors in mice.
So-called uveal melanoma — cancer that attacks parts of the eye that contain pigment cells — affects about 2,000 people in the United States each year. If the cancer hasn’t spread, patients usually undergo radiation treatment and have the affected eye removed. Oftentimes, however, the cancer spreads to the liver and quickly kills patients.
The study, published in the May 29 online issue of the journal Cancer Cell, offers insight into genetic mutations found in about 70 percent of the eye tumors. It also reveals a pathway that could be a target for medications.
The researchers suggest an existing drug, verteporfin (brand name Visudyne), could be a possible treatment. Tests on mice are promising, the study authors noted.
“The beauty of our study is its simplicity,” said study co-author Kun-Liang Guan, professor of pharmacology at University of California, San Diego Moores Cancer Center. “The genetics of this cancer are very simple and our results have clear implications for therapeutic treatments for the disease.”
This cancer is “caused by a very simple genetic mechanism,” Guan said in a university news release. “And we have a drug that works on this mechanism. The clinical applications are very direct,” Guan added.
However, results achieved in animal studies are not always replicated in humans.
More information
For more about melanoma of the eye, visit the U.S. National Library of Medicine.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.